TCL Archive NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC May 23, 1980
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006